Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2023
Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized TrialCindy Neuzillet, Olivier Bouché, Christophe Tournigand, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 20, 2020
International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancerMorten Aa Petersen, Neil K Aaronson, Thierry Conroy, et al.
Targeted Oncology|November 20, 2012
Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trialChristophe Le Tourneau, Maud Kamal, Olivier Trédan, et al.
Psycho-Oncology|June 22, 2019
Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): Results from the international psychometric validationJoachim Weis, Markus A Wirtz, Krzysztof A Tomaszewski, et al.
The Lancet. Oncology|February 22, 2014
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trialThierry Conroy, Marie-Pierre Galais, Jean-Luc Raoul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical TrialRémy Nicolle, Jean-Baptiste Bachet, Alexandre Harlé, et al.
Nature Reviews. Disease Primers|May 7, 2026
Pancreatic cancerSusanne Roth, Minoti Apte, Vinod P Balachandran, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 17, 2018
Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)Cindy Neuzillet, Sébastien Gaujoux, Nicolas Williet, et al.
The Lancet. Oncology|July 5, 2005
Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trialBernard Nordlinger, Philippe Rougier, Jean-Pierre Arnaud, et al.
Clinical Colorectal Cancer|July 18, 2019
Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA StudyChristophe Borg, Georges Mantion, Frank Boudghène, et al.
Pageof 12